SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Samrat Pharmachem informs about AGM

05 Sep 2017 Evaluate

Samrat Pharmachem has informed about the 25th AGM of the Company to be held on Sep 23, 2017 at the Registered Office of the Company.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

213.00 -5.90 (-2.70%)
24-Apr-2026 12:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.00
Dr. Reddys Lab 1334.95
Cipla 1299.00
Zydus Lifesciences 931.00
Lupin 2282.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×